<?xml version="1.0" encoding="UTF-8"?>
<ref id="R13">
 <label>13</label>
 <element-citation publication-type="journal">
  <name>
   <surname>Fesnak</surname>
   <given-names>AD</given-names>
  </name>
  <name>
   <surname>June</surname>
   <given-names>CH</given-names>
  </name>
  <name>
   <surname>Levine</surname>
   <given-names>BL</given-names>
  </name>
  <article-title>Engineered T cells: the promise and challenges of cancer immunotherapy</article-title>
  <source>Nat Rev Cancer</source>
  <year>2016</year>
  <volume>16</volume>
  <issue>9</issue>
  <fpage>566</fpage>
  <lpage>581</lpage>
  <pub-id pub-id-type="doi">10.1038/nrc.2016.97</pub-id>
  <?supplied-pmid 27550819?>
  <pub-id pub-id-type="pmid">27550819</pub-id>
 </element-citation>
</ref>
